知镜 Cognispect · 医学文献与研究工作台

Losartan Is Not Associated With Decreased Postoperative Arthrofibrosis After Hip Arthroscopy.

Abid R, Burkhart RJ, Moyal AJ, Adelstein JM, Apostolakos JM, Calcei JG, Wetzel RJ, Salata MJ.
Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association · 2026-08-24 · PMID 42638305

文献摘要

Purpose To determine whether losartan is associated with lower prevalence of hip adhesions, instability, and repeat procedures after hip arthroscopy and to assess this association among men, women, and patients under 30 years of age. Methods The TriNetX database was queried to identify all patients who underwent hip arthroscopy. Two cohorts were generated: one consisting of patients prescribed losartan after surgery and a comparison group excluding patients with any documented prescription for commonly used angiotensin-converting enzyme inhibitors or angiotensin-receptor II blockers. After 1:1 propensity score matching by age, sex, body mass index, essential hypertension, lower respiratory disease, nicotine dependence, diabetes mellitus, anemia, chronic kidney disease, heart failure, and metabolic disease, both cohorts included 947 patients. Rates of medical and orthopaedic complications were analyzed at 30, 90, and 180 days and at 2 years. A subanalysis was performed for patients under 30 years of age. Results Rates of lysis of adhesions were low at all time points in both cohorts of 947 patients. This held true for other orthopaedic complications. Rates of serious medical complications were low and had no significant differences between cohorts. Subanalysis of cohorts with women (627 patients), men (308 patients), and patients 29-years-old or less (388 patients) also showed similar rates of lysis of adhesions. Conclusions Orthopaedic complications after hip arthroscopy are very rare regardless of whether or not postoperative losartan is prescribed. Serious medical complications were also rare in both cohorts. These results were consistent when stratified by sex and among patients 29-years-old or younger. Level of evidence Level III, retrospective cohort study.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。